Company Email Format Management

Op2Lysis

Biotechnology Research Gip Cyceron, Fr 7 employees

Employees: 7
Contacts: 2
Emails: 2

www.op2lysis.com LinkedIn Crunchbase

Op2Lysis Overview

Headquarters: Gip Cyceron, Fr
Website: www.op2lysis.com
Industry: Biotechnology Research
Employees: 7
Founded: 2016
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Cardiovascular Cérébrovascular drug development

About Op2Lysis

Op2Lysis develops new treatments for patients suffering from thrombosis at the cerebrovascular level, with an initial focus on the hemorrhagic form of stroke. Indeed, there is no currently approved and available therapeutic solution for these patients. The company develops its game-changing NANOp2Lysis platform, associating a breakthrough vectorisation technology, industrial know-how enabling clinical quality production, and preclinical expertise to propose predictive and translational models, a first in this field. O2L-001, the first product resulting from this technology, will soon enter regulatory toxicology with the aim of applying for clinical trial authorisation in patients in North America and Europe.

Op2Lysis Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Op2Lysis Org Chart

Sample employees and titles

Name	Title	Location	Contact
Audrey Thiebaut	R&D Project Manager	Caen, Normandy, France	Email
Philippe Monteyne	Partner at Aliath Bioventures		View
Jérôme Parcq	Entrepreneur - Seasoned General Manager	Caen, Normandy, France	Email
Thierry Sempere	Expert for Finance and Administration		View